Raymond James & Associates’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-13
| Closed | -$25K | – | 4113 |
|
|
2021
Q3 | $25K | Hold |
13
| – | – | ﹤0.01% | 3885 |
|
|
2021
Q2 | $36K | Hold |
13
| – | – | ﹤0.01% | 3853 |
|
|
2021
Q1 | $56K | Sell |
13
-1
| -7% | -$4.31K | ﹤0.01% | 3761 |
|
|
2020
Q4 | $81K | Hold |
14
| – | – | ﹤0.01% | 3535 |
|
|
2020
Q3 | $86K | Buy |
14
+2
| +17% | +$12.3K | ﹤0.01% | 3353 |
|
|
2020
Q2 | $65K | Hold |
12
| – | – | ﹤0.01% | 3302 |
|
|
2020
Q1 | $44K | Buy |
12
+3
| +33% | +$11K | ﹤0.01% | 3290 |
|
|
2019
Q4 | $43K | Buy |
+9
| New | +$43K | ﹤0.01% | 3496 |
|
|
2018
Q4 | – | Sell |
-6
| Closed | -$5K | – | 3585 |
|
|
2018
Q3 | $5K | Hold |
6
| – | – | ﹤0.01% | 3491 |
|
|
2018
Q2 | $6K | Buy |
+6
| New | +$6K | ﹤0.01% | 3450 |
|
|
2015
Q2 | – | Sell |
-14
| Closed | -$253K | – | 2453 |
|
|
2015
Q1 | $253K | Buy |
+14
| New | +$253K | ﹤0.01% | 2251 |
|